The Paradox of Coenzyme Q10 in Aging

Autor: José L. Quiles, Pilar González-García, Maurizio Battino, Luis C. López, M Elena Díaz-Casado, Eliana Barriocanal-Casado, Alfonso Varela-López
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
0301 basic medicine
Aging
antioxidant
Mitochondrial Diseases
Antioxidant
Ubiquinone
aging-related diseases
medicine.medical_treatment
mitohormesis
Mitochondrion
medicine.disease_cause
Antioxidants
Mice
chemistry.chemical_compound
0302 clinical medicine
Inner mitochondrial membrane
Muscle Weakness
Nutrition and Dietetics
food and beverages
Middle Aged
Aging-related diseases
Cell biology
Mitochondria
mitochondria
Female
lcsh:Nutrition. Foods and food supply
Adult
lcsh:TX341-641
Young Adult
03 medical and health sciences
Hormesis
Mitohormesis
Biosynthesis
medicine
Animals
Humans
Caenorhabditis elegans
Coenzyme Q10
anti-aging
Diet
Rats
Metabolic pathway
030104 developmental biology
chemistry
Coenzyme Q – cytochrome c reductase
Ataxia
diet
030217 neurology & neurosurgery
Oxidative stress
Food Science
Zdroj: Digibug. Repositorio Institucional de la Universidad de Granada
instname
Nutrients, Vol 11, Iss 9, p 2221 (2019)
Popis: Coenzyme Q (CoQ) is an essential endogenously synthesized molecule that links different metabolic pathways to mitochondrial energy production thanks to its location in the mitochondrial inner membrane and its redox capacity, which also provide it with the capability to work as an antioxidant. Although defects in CoQ biosynthesis in human and mouse models cause CoQ deficiency syndrome, some animals models with particular defects in the CoQ biosynthetic pathway have shown an increase in life span, a fact that has been attributed to the concept of mitohormesis. Paradoxically, CoQ levels decline in some tissues in human and rodents during aging and coenzyme Q10 (CoQ10) supplementation has shown benefits as an anti-aging agent, especially under certain conditions associated with increased oxidative stress. Also, CoQ10 has shown therapeutic benefits in aging-related disorders, particularly in cardiovascular and metabolic diseases. Thus, we discuss the paradox of health benefits due to a defect in the CoQ biosynthetic pathway or exogenous supplementation of CoQ10.
This work was supported by grants from Ministerio de Ciencia, Innovación y Universidades, Spain, and the ERDF (Grant Number RTI2018-093503-B-I00), from the Muscular Dystrophy Association (grant number 602322) and from the University of Granada (grant reference “UNETE”, UCE-PP2017-06). E.B.-C. is supported by the Junta de Andalucía. P.G.-G. is a “FPU fellow” from the Ministerio de Educación Cultura y Deporte, Spain
Databáze: OpenAIRE